Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital

A review of one institution's experience

Brenda J. Leonhardi, Mary E. Boyle, Karen A. Beer, Karen M. Seifert, Marilyn Bailey, Victoria Miller-Cage, Janna C. Castro, Peggy B. Bourgeois, Curtiss B. Cook

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background: This article reviews the performance of our hospital's inpatient insulin pump policy. Methods: Twenty-five hospital admissions of 21 unique patients receiving outpatient insulin pump therapy were reviewed. Results: Between November 1, 2005, and November 30, 2006, there were 25 hospital admissions involving 21 patients receiving outpatient insulin pump therapy. The average age and duration of diabetes among these 21 patients was 50 and 29 years, respectively; 67% were women, 90% had type 1 diabetes, and all were white. The mean length of hospital stay was 4 days, and the average reported length of insulin pump therapy was 4 years. Patients in 16 of the admissions were identified as candidates for continued use of the insulin pump during the hospital stay. Over 90% of patients remaining on the insulin pump had documentation by nursing of the presence of the pump at the time of admission; 100% of the patients had an admission glucose recorded; 88% had a record of signed patient consent; 81% had evidence of completed preprinted insulin pump orders; 75% received a required endocrine consultation; and 75% of cases had documentation of completed bedside flow sheet. A high frequency of both hypoglycemic and hyperglycemic events occurred in the patients; however, no adverse events were related directly to the insulin pump. Conclusions: Insulin pump therapy can be safely continued in the hospital setting. While staff compliance with required procedures was high, there was still room for improvement. More data are needed, however, on whether this method of insulin delivery is effective for controlling hyperglycemia in hospitalized patients.

Original languageEnglish (US)
Pages (from-to)948-962
Number of pages15
JournalJournal of diabetes science and technology
Volume2
Issue number6
StatePublished - Nov 2008

Fingerprint

Subcutaneous Infusions
Infusion Pumps
Insulin
Pumps
Therapeutics
Length of Stay
Medical problems
Documentation
Outpatients
Nursing
Patient Admission
Type 1 Diabetes Mellitus
Hypoglycemic Agents
Hyperglycemia
Glucose
Inpatients
Referral and Consultation

Keywords

  • Continuous subcutaneous insulin infusion
  • Diabetes mellitus
  • Hospitalizations
  • Insulin infusion
  • Insulin pumps

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Bioengineering
  • Biomedical Engineering

Cite this

Leonhardi, B. J., Boyle, M. E., Beer, K. A., Seifert, K. M., Bailey, M., Miller-Cage, V., ... Cook, C. B. (2008). Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: A review of one institution's experience. Journal of diabetes science and technology, 2(6), 948-962.

Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital : A review of one institution's experience. / Leonhardi, Brenda J.; Boyle, Mary E.; Beer, Karen A.; Seifert, Karen M.; Bailey, Marilyn; Miller-Cage, Victoria; Castro, Janna C.; Bourgeois, Peggy B.; Cook, Curtiss B.

In: Journal of diabetes science and technology, Vol. 2, No. 6, 11.2008, p. 948-962.

Research output: Contribution to journalArticle

Leonhardi, BJ, Boyle, ME, Beer, KA, Seifert, KM, Bailey, M, Miller-Cage, V, Castro, JC, Bourgeois, PB & Cook, CB 2008, 'Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: A review of one institution's experience', Journal of diabetes science and technology, vol. 2, no. 6, pp. 948-962.
Leonhardi, Brenda J. ; Boyle, Mary E. ; Beer, Karen A. ; Seifert, Karen M. ; Bailey, Marilyn ; Miller-Cage, Victoria ; Castro, Janna C. ; Bourgeois, Peggy B. ; Cook, Curtiss B. / Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital : A review of one institution's experience. In: Journal of diabetes science and technology. 2008 ; Vol. 2, No. 6. pp. 948-962.
@article{37a633cbf652476299ef7ea0873be37b,
title = "Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: A review of one institution's experience",
abstract = "Background: This article reviews the performance of our hospital's inpatient insulin pump policy. Methods: Twenty-five hospital admissions of 21 unique patients receiving outpatient insulin pump therapy were reviewed. Results: Between November 1, 2005, and November 30, 2006, there were 25 hospital admissions involving 21 patients receiving outpatient insulin pump therapy. The average age and duration of diabetes among these 21 patients was 50 and 29 years, respectively; 67{\%} were women, 90{\%} had type 1 diabetes, and all were white. The mean length of hospital stay was 4 days, and the average reported length of insulin pump therapy was 4 years. Patients in 16 of the admissions were identified as candidates for continued use of the insulin pump during the hospital stay. Over 90{\%} of patients remaining on the insulin pump had documentation by nursing of the presence of the pump at the time of admission; 100{\%} of the patients had an admission glucose recorded; 88{\%} had a record of signed patient consent; 81{\%} had evidence of completed preprinted insulin pump orders; 75{\%} received a required endocrine consultation; and 75{\%} of cases had documentation of completed bedside flow sheet. A high frequency of both hypoglycemic and hyperglycemic events occurred in the patients; however, no adverse events were related directly to the insulin pump. Conclusions: Insulin pump therapy can be safely continued in the hospital setting. While staff compliance with required procedures was high, there was still room for improvement. More data are needed, however, on whether this method of insulin delivery is effective for controlling hyperglycemia in hospitalized patients.",
keywords = "Continuous subcutaneous insulin infusion, Diabetes mellitus, Hospitalizations, Insulin infusion, Insulin pumps",
author = "Leonhardi, {Brenda J.} and Boyle, {Mary E.} and Beer, {Karen A.} and Seifert, {Karen M.} and Marilyn Bailey and Victoria Miller-Cage and Castro, {Janna C.} and Bourgeois, {Peggy B.} and Cook, {Curtiss B.}",
year = "2008",
month = "11",
language = "English (US)",
volume = "2",
pages = "948--962",
journal = "Journal of diabetes science and technology",
issn = "1932-2968",
publisher = "Diabetes Technology Society",
number = "6",

}

TY - JOUR

T1 - Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital

T2 - A review of one institution's experience

AU - Leonhardi, Brenda J.

AU - Boyle, Mary E.

AU - Beer, Karen A.

AU - Seifert, Karen M.

AU - Bailey, Marilyn

AU - Miller-Cage, Victoria

AU - Castro, Janna C.

AU - Bourgeois, Peggy B.

AU - Cook, Curtiss B.

PY - 2008/11

Y1 - 2008/11

N2 - Background: This article reviews the performance of our hospital's inpatient insulin pump policy. Methods: Twenty-five hospital admissions of 21 unique patients receiving outpatient insulin pump therapy were reviewed. Results: Between November 1, 2005, and November 30, 2006, there were 25 hospital admissions involving 21 patients receiving outpatient insulin pump therapy. The average age and duration of diabetes among these 21 patients was 50 and 29 years, respectively; 67% were women, 90% had type 1 diabetes, and all were white. The mean length of hospital stay was 4 days, and the average reported length of insulin pump therapy was 4 years. Patients in 16 of the admissions were identified as candidates for continued use of the insulin pump during the hospital stay. Over 90% of patients remaining on the insulin pump had documentation by nursing of the presence of the pump at the time of admission; 100% of the patients had an admission glucose recorded; 88% had a record of signed patient consent; 81% had evidence of completed preprinted insulin pump orders; 75% received a required endocrine consultation; and 75% of cases had documentation of completed bedside flow sheet. A high frequency of both hypoglycemic and hyperglycemic events occurred in the patients; however, no adverse events were related directly to the insulin pump. Conclusions: Insulin pump therapy can be safely continued in the hospital setting. While staff compliance with required procedures was high, there was still room for improvement. More data are needed, however, on whether this method of insulin delivery is effective for controlling hyperglycemia in hospitalized patients.

AB - Background: This article reviews the performance of our hospital's inpatient insulin pump policy. Methods: Twenty-five hospital admissions of 21 unique patients receiving outpatient insulin pump therapy were reviewed. Results: Between November 1, 2005, and November 30, 2006, there were 25 hospital admissions involving 21 patients receiving outpatient insulin pump therapy. The average age and duration of diabetes among these 21 patients was 50 and 29 years, respectively; 67% were women, 90% had type 1 diabetes, and all were white. The mean length of hospital stay was 4 days, and the average reported length of insulin pump therapy was 4 years. Patients in 16 of the admissions were identified as candidates for continued use of the insulin pump during the hospital stay. Over 90% of patients remaining on the insulin pump had documentation by nursing of the presence of the pump at the time of admission; 100% of the patients had an admission glucose recorded; 88% had a record of signed patient consent; 81% had evidence of completed preprinted insulin pump orders; 75% received a required endocrine consultation; and 75% of cases had documentation of completed bedside flow sheet. A high frequency of both hypoglycemic and hyperglycemic events occurred in the patients; however, no adverse events were related directly to the insulin pump. Conclusions: Insulin pump therapy can be safely continued in the hospital setting. While staff compliance with required procedures was high, there was still room for improvement. More data are needed, however, on whether this method of insulin delivery is effective for controlling hyperglycemia in hospitalized patients.

KW - Continuous subcutaneous insulin infusion

KW - Diabetes mellitus

KW - Hospitalizations

KW - Insulin infusion

KW - Insulin pumps

UR - http://www.scopus.com/inward/record.url?scp=77649085442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649085442&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 948

EP - 962

JO - Journal of diabetes science and technology

JF - Journal of diabetes science and technology

SN - 1932-2968

IS - 6

ER -